Key considerations for cancer pharmacotherapy 1

Published on May 29, 2017   42 min
0:00
Hello, my name is Chris Walko and I am a personalized medicine specialist at Moffitt Cancer Center in Tampa, Florida in the United States. And today we're going to be discussing the treatment paradigms used to treat cancer and I'm going to aim to provide an overview of key considerations for cancer pharmacotherapies. I've worked in the oncology realm for more than 10 years as a pharmacist and a clinical pharmacist and an educator and now my role is actually in chairing a Molecular Tumor Board and helping to use cancer genetics to personalize therapy in direct treatment.
0:38
So I'm really excited to see how we translate all of what we've learned over the years and throughout this lecture we're going to talk a little bit about the history of how we've treated cancer and ultimately end up with kind of where we are today with the targeted therapies intermixed with the cytotoxic therapies and the immunotherapies. So we will review this different treatment modalities used to treat cancer in this section including both local therapy, so radiation and surgery as well as systemic therapies. And we will also begin to delve into the newer targeted therapies and the immunotherapies as I said. This lecture is meant to provide an overview that will be further translated into specific malignancies in the subsequent learning module.
Hide

Key considerations for cancer pharmacotherapy 1

Embed in course/own notes